Saturday 17 October 2026
Export SOPH’s income statement to Excel — free account
SOPHiA GENETICS SA
SOPH Healthcare Health Information Services
SOPHiA GENETICS SA’s revenue for fiscal 2025 (year ended December 2025) was $77.3 million, up 18.6% from fiscal 2024. In the quarter to June 2026, revenue grew 27.2%, EPS grew 9.88%, free cash flow grew 6.50% and total debt rose 1.12%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
6.73
0.56
−7.68%
Follow SOPH
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
2 | 3 | 4 | 3 | 4 | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z-Score |
(3.43) | (2.33) | 0.54 | (0.06) | 9.87 | — | — | — |
P/S ratio |
4.08 | 3.11 | 5.01 | 3.03 | 19.28 | 24.00 | 24.00 | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z″-Score (non-manufacturers) |
(10.93) | (7.33) | (1.93) | 2.95 | 8.02 | 2.42 | (7.77) | — |
Beneish M-Score |
(3.30) | (3.44) | (2.20) | (2.64) | (2.70) | (2.85) | — | — |
P/Operating CF |
(38.77) | (18.98) | (27.70) | (13.96) | (50.57) | (50.53) | (50.53) | — |
P/B ratio |
6.69 | 2.10 | 2.07 | 0.72 | 2.83 | 11.53 | 11.53 | — |
Price to Tangible BV |
28.03 | 3.01 | 2.52 | 0.80 | 3.00 | 14.33 | 14.33 | — |
EV/Sales |
3.81 | 2.11 | 3.30 | (0.39) | 13.04 | 22.24 | 22.24 | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.23 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
(8.20) | (3.09) | (4.24) | 0.27 | (9.10) | (16.49) | (16.49) | — |
EV/FCF |
(8.04) | (3.06) | (4.09) | 0.25 | (8.68) | (15.91) | (15.91) | — |
Quick Ratio |
1.69 | 3.27 | 3.84 | 6.91 | 9.50 | 4.80 | 1.37 | — |
Current Ratio |
1.96 | 3.71 | 4.16 | 7.32 | 9.89 | 5.08 | 1.75 | — |
Net Debt/EBITDA |
0.37 | 1.16 | 1.85 | 2.00 | 3.74 | 2.69 | 0.48 | — |
Debt/Assets |
29.28% | 8.52% | 0.00% | 5.76% | 3.51% | 2.52% | 7.43% | 0.00% |
Debt/Equity |
1.01 | 0.14 | 0.00 | 0.07 | 0.04 | 0.03 | 0.17 | — |
Asset Turnover |
0.49 | 0.36 | 0.28 | 0.17 | 0.18 | 0.31 | 0.98 | — |
Operating CF/Net income |
0.45 | 0.71 | 0.62 | 0.80 | 0.79 | 0.81 | 0.94 | — |
Capex/Depreciation |
(0.07) | (0.05) | (0.21) | (0.82) | (0.78) | (0.32) | (1.59) | — |
Interest Coverage |
(15.57) | (34.80) | (127.26) | (66.33) | (3,574.45) | (389.45) | (375.43) | — |
| (110.00%) | (50.41%) | (44.93%) | (36.78%) | (39.20%) | (64.09%) | (55.05%) | — | |
| (49.63%) | (34.58%) | (35.10%) | (31.01%) | (32.58%) | (42.81%) | (130.83%) | — | |
ROIC |
(180.23%) | (141.03%) | (165.89%) | (154.31%) | (209.50%) | (359.77%) | (263.58%) | — |
Return on Tangible Assets |
(145.71%) | (80.31%) | (65.88%) | (49.53%) | (28.46%) | (43.77%) | (205.85%) | — |
Average Days of Receivables |
70.86 | 41.65 | 79.34 | 51.03 | 56.65 | 81.78 | 114.11 | — |
Research and Development Expense of Revenue |
44.28% | 52.73% | 59.27% | 74.37% | 65.71% | 65.45% | 59.21% | — |
Selling, General and Administrative Expense of Revenue |
114.77% | 117.11% | 131.03% | 176.79% | 173.65% | 128.16% | 138.33% | — |
Intangible Assets out of Total Assets |
0.22 | 0.19 | 0.13 | 0.08 | 0.05 | 0.10 | 0.20 | 0.00 |
Share Based Compensation of Revenue |
20.97% | 25.30% | 24.44% | 28.62% | 21.05% | 4.79% | 0.00% | — |
Graham Net Nets |
(0.05) | 0.20 | 0.30 | 1.06 | 0.31 | 0.06 | 0.06 | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
(25.12%) | (30.94%) | (25.26%) | (60.89%) | (9.39%) | (6.54%) | (6.54%) | — |
Free Cash Flow Yield |
(11.61%) | (22.17%) | (16.09%) | (51.76%) | (7.79%) | (5.82%) | (5.82%) | — |
Revenue per Share |
1.14 | 0.99 | 0.96 | 0.74 | 0.73 | 0.67 | 0.67 | — |
Operating CF per Share |
(0.53) | (0.67) | (0.75) | (1.09) | (1.05) | (0.75) | (0.84) | — |
Capex per Share |
(0.01) | (0.01) | (0.03) | (0.07) | (0.05) | (0.02) | (0.08) | — |
Free Cash Flow per Share |
(0.54) | (0.68) | (0.78) | (1.16) | (1.10) | (0.77) | (0.92) | — |
Cash per Share |
1.04 | 1.21 | 1.90 | 2.79 | 4.80 | 2.30 | 0.49 | — |
Shareholders Equity per Share |
0.70 | 1.46 | 2.34 | 3.12 | 4.98 | 2.37 | 0.59 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
0.70 | 1.46 | 2.34 | 3.12 | 4.98 | 2.37 | 0.59 | — |
Free Cash Flow |
(36.57) | (44.95) | (50.33) | (74.65) | (60.75) | (32.50) | (34.71) | — |
Working Capital |
48.55 | 72.60 | 112.43 | 169.45 | 254.25 | 88.11 | 14.50 | — |
Capital Expenditures |
(0.68) | (0.44) | (1.76) | (4.56) | (2.81) | (0.77) | (3.03) | — |
Net Current Asset Value |
(16.81) | 40.59 | 93.33 | 152.55 | 238.08 | 78.09 | 4.36 | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.21 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.01 | 0.01 | 0.03 | 0.10 | 0.07 | 0.03 | 0.12 | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
1.68 | 1.65 | 1.12 | 0.78 | 0.77 | 1.35 | 1.00 | — |
Cash ROIC |
(22.14%) | (23.67%) | (18.32%) | (19.01%) | (11.01%) | (16.15%) | (77.96%) | — |
Accounts Receivable Turnover |
6.89 | 6.21 | 6.17 | 7.36 | 6.40 | 3.97 | 2.89 | — |
Accounts Payable Turnover |
3.55 | 4.00 | 3.36 | 2.52 | 2.41 | 1.89 | 5.00 | — |
Inventory Turnover |
4.12 | 3.44 | 3.34 | 3.00 | 3.34 | 3.06 | 2.15 | — |
Average Days of Payables |
129.81 | 89.72 | 101.13 | 138.36 | 161.47 | 201.33 | 261.68 | — |
Days of Inventory on Hand |
92.01 | 100.86 | 121.59 | 115.41 | 137.31 | 115.34 | 174.94 | — |
Average Receivables |
11.22 | 10.50 | 10.10 | 6.46 | 6.32 | 7.15 | 8.78 | — |
Average Payables |
7.09 | 5.31 | 5.79 | 6.46 | 6.32 | 5.65 | 1.51 | — |
Average Inventory |
6.11 | 6.18 | 5.82 | 5.44 | 4.56 | 3.50 | 3.50 | — |
Average Assets |
159.17 | 180.73 | 225.00 | 282.01 | 226.14 | 91.89 | 25.83 | — |
Average Common Equity |
71.82 | 123.97 | 175.79 | 237.77 | 187.96 | 61.38 | 61.38 | — |
Columns are period end dates